Treatment of cutaneous leishmaniasis in Colombia with dapsone

Lancet. 1998 Feb 14;351(9101):498-9. doi: 10.1016/S0140-6736(05)78687-6.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use*
  • Colombia / epidemiology
  • Dapsone / administration & dosage
  • Dapsone / therapeutic use*
  • Female
  • Humans
  • Leishmaniasis, Cutaneous / drug therapy*
  • Leishmaniasis, Cutaneous / epidemiology
  • Male
  • Patient Compliance
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Dapsone